The increase was statistically significant compared with the no-treatment or PBS-treated control groups but was less prominent compared with murine subcutaneous or intratibial 4T1 tumor-bearing mice, suggesting that PTHrP is not the only but one of the M-MDSC mobilizing factors. Here, PTHLH is linked to neoplasm.